These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19875754)

  • 1. Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.
    Edeline J; Laguerre B; Rolland Y; Patard JJ
    Ann Oncol; 2010 Jan; 21(1):186-7. PubMed ID: 19875754
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute aortic dissection in a patient with metastatic renal cell carcinoma treated with axitinib.
    Niwa N; Nishiyama T; Ozu C; Yagi Y; Saito S
    Acta Oncol; 2015 Apr; 54(4):561-2. PubMed ID: 25291078
    [No Abstract]   [Full Text] [Related]  

  • 3. Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment.
    Huang J; Wang T; Huang Y
    Med Oncol; 2013 Mar; 30(1):436. PubMed ID: 23283650
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute aortic dissection in a patient receiving multiple tyrosine kinase inhibitors for 5 years.
    Funahashi Y; Sassa N; Inada-Inoue M; Ando Y; Matsukawa Y; Gotoh M
    Aktuelle Urol; 2014 Mar; 45(2):132-4. PubMed ID: 24700069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic dissection during antiangiogenic therapy with sunitinib. A case report.
    Formiga MN; Fanelli MF
    Sao Paulo Med J; 2015; 133(3):275-7. PubMed ID: 25351639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of antiangiogenic therapy-induced hypertension.
    de Jesus-Gonzalez N; Robinson E; Moslehi J; Humphreys BD
    Hypertension; 2012 Sep; 60(3):607-15. PubMed ID: 22851729
    [No Abstract]   [Full Text] [Related]  

  • 7. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
    Méjean A; Ravaud A; Thezenas S; Colas S; Beauval JB; Bensalah K; Geoffrois L; Thiery-Vuillemin A; Cormier L; Lang H; Guy L; Gravis G; Rolland F; Linassier C; Lechevallier E; Beisland C; Aitchison M; Oudard S; Patard JJ; Theodore C; Chevreau C; Laguerre B; Hubert J; Gross-Goupil M; Bernhard JC; Albiges L; Timsit MO; Lebret T; Escudier B
    N Engl J Med; 2018 Aug; 379(5):417-427. PubMed ID: 29860937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
    De Vincenzo F; Zucali PA; Ceresoli GL; Colombo P; Simonelli M; Lorenzi E; Perrino M; Gianoncelli L; De Sanctis R; Graziotti P; Santoro A
    J Clin Oncol; 2011 Jun; 29(18):e529-31. PubMed ID: 21483010
    [No Abstract]   [Full Text] [Related]  

  • 9. Sunitinib-related interstitial pneumonia after treatment with temsirolimus: a case of possible recall phenomenon.
    Kushima H; Ishii H; Kadota J
    Int J Urol; 2014 Apr; 21(4):420-1. PubMed ID: 24168290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum with the use of sunitinib.
    Nadauld LD; Miller MB; Srinivas S
    J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
    [No Abstract]   [Full Text] [Related]  

  • 11. Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma.
    Quintyne KI; Neenan T; Casserly L; Gupta R
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24872478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.
    Shaw GL; Hussain M; Nair R; Bycroft J; Beltran L; Green JS; Powles T; Peters JL
    Urol Int; 2012; 89(1):83-8. PubMed ID: 22614181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
    Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
    Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cardiac failure after sunitinib.
    Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
    Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
    [No Abstract]   [Full Text] [Related]  

  • 15. Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients?
    Mir MH; Changal KH; Aziz SA; Bhat GM; Lone AR
    Int Urol Nephrol; 2016 Nov; 48(11):1811-1816. PubMed ID: 27448573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma.
    Ballardini P; Margutti G; Aliberti C; Manfredini R
    Clin Drug Investig; 2009; 29(7):487-490. PubMed ID: 19499966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaw related to sunitinib.
    Koch FP; Walter C; Hansen T; Jäger E; Wagner W
    Oral Maxillofac Surg; 2011 Mar; 15(1):63-6. PubMed ID: 20401503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
    Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
    Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib still fi rst-line therapy for metastatic renal cancer.
    Bagcchi S
    Lancet Oncol; 2014 Sep; 15(10):e420. PubMed ID: 25328943
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
    Park CY
    Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.